Literature DB >> 1629311

Simultaneous determination of caffeine and its primary demethylated metabolites in human plasma by high-performance liquid chromatography.

E Tanaka1.   

Abstract

An improved high-performance liquid chromatographic method for the simultaneous determination of caffeine and its three primary metabolites (theophylline, theobromine and paraxanthine) in human plasma is described. The four substances were separated on a reversed-phase column (5 microns TSK gel ODS-80TM, 150 mm x 4.6 mm I.D.) by use of the mobile phase methanol-0.1 M NaH2PO4 (30:70, v/v) with a flow-rate of 0.8 ml/min. Absorbance was monitored at 274 nm. The detection limit was 5 ng/ml for theobromine and caffeine and 10 ng/ml for paraxanthine and theophylline. The linearity and reproducibility were sufficient for drug monitoring of caffeine and its primary methylxanthines.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1629311     DOI: 10.1016/0378-4347(92)80163-k

Source DB:  PubMed          Journal:  J Chromatogr


  4 in total

1.  Measurement of caffeine and its three primary metabolites in human plasma by HPLC-ESI-MS/MS and clinical application.

Authors:  Feng Chen; Zhe-Yi Hu; Robert B Parker; S Casey Laizure
Journal:  Biomed Chromatogr       Date:  2017-01-04       Impact factor: 1.902

2.  Fluvoxamine impairs single-dose caffeine clearance without altering caffeine pharmacodynamics.

Authors:  Kerry E Culm-Merdek; Lisa L von Moltke; Jerold S Harmatz; David J Greenblatt
Journal:  Br J Clin Pharmacol       Date:  2005-11       Impact factor: 4.335

3.  Caffeine increases striatal dopamine D2/D3 receptor availability in the human brain.

Authors:  N D Volkow; G-J Wang; J Logan; D Alexoff; J S Fowler; P K Thanos; C Wong; V Casado; S Ferre; D Tomasi
Journal:  Transl Psychiatry       Date:  2015-04-14       Impact factor: 6.222

4.  Pharmacokinetics of Caffeine following a Single Administration of Coffee Enema versus Oral Coffee Consumption in Healthy Male Subjects.

Authors:  Supanimit Teekachunhatean; Nisanuch Tosri; Noppamas Rojanasthien; Somdet Srichairatanakool; Chaichan Sangdee
Journal:  ISRN Pharmacol       Date:  2013-03-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.